Nobell Foods, a startup specializing in manufacturing cheese from plant-derived dairy proteins, has leased 66,234 square feet of Class A office/life science space for its new headquarters in South San Francisco, California in a deal brokered by Cushman & Wakefield.
Relocating and expanding its headquarters from a nearby location in SSF, Nobell Foods’ new headquarters is located in a newly constructed building at 700 Gateway Blvd deemed Phase III of Gateway of Pacific, a brand new state-of-the-art campus development that will total 2.2 msf when fully built out. The property is owned and being developed over five phases by Biomed Realty Trust.
Cushman & Wakefield Executive Director Marc Pope and Senior Director Gary Boitano represented the tenant in the transaction. Scott Altick of Biomed Realty Trust self-represented ownership.
“We are excited to be part of the growth of Nobell Foods as they relocate to their new headquarters in South San Francisco,” says Pope. “Their leadership is incredible, and their new location will really reflect the quality of the company. We look forward to their continued success at BMR’s Gateway of Pacific.”
“South San Francisco is recognized as the Birthplace of Biotechnology and in an area renowned as one of the world’s most renowned biotech clusters This transaction adds to the strong momentum we have maintained for many years from biotech and life science users here along the San Francisco Bay Area Peninsula,” adds Boitano.
700 Gateway is located at the entrance to South San Francisco at a prominent intersection to its life science cluster. Providing identity from US-101 freeway, the location is convenient to Caltrain, BART, Bay Ferry, SFO Airport, US-101, I-380 and I-280.
Founded and led by Magi Richani, Nobell Foods creates key dairy proteins, including casein, from high-quality soybeans, enabling the brand to make cheeses that taste, smell, melt, stretch, and even age like those made from animals, and challenging the way we talk about, think about, and eat cheese. In July 2021, the company announced it had raised US $75 million Series B funding.